Clin2
NCT07346235Possibly a fitNot yet recruiting

Comparing two FSH doses for IVF patients with normal ovarian reserve

Infertility, Female

Part of Women’s health & pregnancy clinical trials.

This trial tests whether a lower or higher dose of follicle-stimulating hormone (FSH) works better for women with normal egg supply. If you are starting your first or second IVF cycle, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
440 people
Ages
18 years to 39 years
Study type
Interventional

Who can take part

  • Your body mass index (BMI) is between 18 and 30.
  • Your blood test (AMH) shows normal egg supply: 1.2–3.5 ng/mL.
  • Your antral follicle count (AFC) by ultrasound is 8–20.
  • This is your first or second IVF or ICSI cycle.
  • You are using a GnRH antagonist protocol.
  • Both ovaries are intact and reachable for egg retrieval.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06193135Recruiting
Comparing two ovarian stimulation medications for egg donors

This trial compares two different medications (Corifollitropin alpha and daily rFSH) to stimulate egg production in healthy egg donors. It aims to see if a single injection of Corifollitropin alpha works as well as the usual daily shots, making the process simpler and more comfortable.

Valencia, Valencia
NCT07772375Not yet recruiting
Comparing two starting hormone doses for IVF in healthy younger women

This trial compares two starting doses of follicle-stimulating hormone (FSH) during in vitro fertilization (IVF) to see which works better. FSH helps your ovaries produce eggs, and the study aims to find the best dose for women with good fertility prospects.

Ho Chi Minh City, Ho Chi Minh City
NCT07121751Not yet recruiting· Phase 4
Better egg stimulation for women with low egg count

This study tests a different type of fertility medication to help women who had fewer than 9 eggs retrieved in a previous IVF cycle. It's designed for women between 18 and 40 with a specific hormone profile, and aims to improve egg collection results.

Budapest
NCT06154083Recruiting· Phase 4
Comparing stimulation doses for IVF with genetic testing

This trial tests two different intensities of ovarian stimulation for women undergoing IVF with genetic testing of embryos. It aims to see which approach leads to more healthy embryos ready for transfer.

Barcelona
NCT06921395Recruiting· Phase 4
Comparing two fertility drugs for IVF in women under 40

This trial tests how well and safely a new drug (Fang Le Shu) works compared to a standard drug (Guo Na Fen) for stimulating the ovaries to produce eggs for IVF. It may help women who have had trouble getting pregnant for at least a year.

Zhengzhou
NCT06995261Recruiting
Follitropin delta in a long hormone-suppression IVF cycle

This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.

Düsseldorf, North Rhine-Westphalia

Hear when a new Infertility, Female trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.